Aqueous Macrophages Contribute to Conserved CCL2 and CXCL10 Gradients in Uveitis
Purpose: Uveitis is a heterogenous group of inflammatory eye disease for which current cytokine-targeted immune therapies are effective for only a subset of patients. We hypothesized that despite pathophysiologic nuances that differentiate individual disease states, all forms of eye inflammation mig...
Main Authors: | Joseph B. Lin, Kathryn L. Pepple, MD, PhD, Christian Concepcion, Yulia Korshunova, PhD, Michael A. Paley, MD, PhD, Grace L. Paley, MD, PhD, Jennifer Laurent, Rajendra S. Apte, MD, PhD, Lynn M. Hassman, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-07-01
|
Series: | Ophthalmology Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666914523001859 |
Similar Items
-
Clinicomolecular Identification of Conserved and Individualized Features of Granulomatous Uveitis
by: Lynn M. Hassman, MD, PhD, et al.
Published: (2021-03-01) -
Can Simvastatin Reduce the Need for Immunomodulatory Drugs to Treat Uveitis?
by: Ahmed Al-Janabi, PhD, FRCOphth, et al.
Published: (2023-12-01) -
A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis
by: Jonas J.W. Kuiper, PhD, et al.
Published: (2022-09-01) -
Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis
by: Rodrigo Jorge, MD, PhD, et al.
Published: (2021-06-01) -
Local Immunity Status and Inflammation Markers in Patients with Endogenous Uveitis
by: Dilorom B. Fayzieva, et al.
Published: (2013-06-01)